Differential expression of innate immunity genes in chronic rhinosinusitis

Kara Y. Detwiller, Timothy Smith, Jeremiah A. Alt, Dennis Trune, Jess C. Mace, Nathan Sautter

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Prior research has identified several components of the innate immune system that may play a significant role in chronic rhinosinusitis (CRS), but the role of innate immunity in patients with CRS is poorly understood. The objective of this study was to determine differential expression of innate immunity genes in the mucosa of patients with CRS with nasal polyposis (CRSwNP) and CRS without nasal polyposis (CRSsNP) when compared with controls.

Methods: Control patients (n = 9) and patients with CRS (n = 36) who failed medical management were prospectively enrolled. Ethmoid mucosa samples were harvested during surgery and quantitative real-time polymerase chain reaction was used to determine levels of mRNA expression of Toll-like receptor (TLR) 2 and TLR9 and interleukin-22 receptor (IL-22R). The average change in crossover threshold and fold change were calculated and differences between controls, CRSwNP, and CRSsNP were compared. Statistical analysis was performed using the Kruskall-Wallis and adjusted Mann-Whitney U tests.

Results: Patients with CRSwNP (n = 16) and CRSsNP (n = 20) showed lower mean expression of TLR2 (p <0.05) compared with controls. Patients with CRSsNP showed significantly higher mean expression of IL-22R (p <0.05) than controls.

Conclusion: The sinonasal innate immune system may have a significant role in the development of CRS. We found differential expression of innate immune mediators between patients with and without nasal polyposis. These results provide further evidence of disruption of innate immunity at the mucosal level in CRS and highlight differences between polyp- and non-polyp-forming CRS phenotypes at the molecular level. In addition to our knowledge, this is the first report of altered IL-22R expression in CRSsNP patients. This study was a part of the clinical trial NCT01332136 registered in www. clinicaltrials.gov.

Original languageEnglish (US)
Pages (from-to)374-377
Number of pages4
JournalAmerican Journal of Rhinology and Allergy
Volume28
Issue number5
DOIs
StatePublished - Sep 1 2014

Fingerprint

Nose
Innate Immunity
Genes
Immune System
Mucous Membrane
Toll-Like Receptor 2
Nonparametric Statistics
Polyps
Real-Time Polymerase Chain Reaction
Clinical Trials
Phenotype
Messenger RNA
Research

ASJC Scopus subject areas

  • Immunology and Allergy
  • Otorhinolaryngology
  • Medicine(all)

Cite this

Differential expression of innate immunity genes in chronic rhinosinusitis. / Detwiller, Kara Y.; Smith, Timothy; Alt, Jeremiah A.; Trune, Dennis; Mace, Jess C.; Sautter, Nathan.

In: American Journal of Rhinology and Allergy, Vol. 28, No. 5, 01.09.2014, p. 374-377.

Research output: Contribution to journalArticle

Detwiller, Kara Y. ; Smith, Timothy ; Alt, Jeremiah A. ; Trune, Dennis ; Mace, Jess C. ; Sautter, Nathan. / Differential expression of innate immunity genes in chronic rhinosinusitis. In: American Journal of Rhinology and Allergy. 2014 ; Vol. 28, No. 5. pp. 374-377.
@article{7c28b19c44484fc991f68dc57049c7b8,
title = "Differential expression of innate immunity genes in chronic rhinosinusitis",
abstract = "Background: Prior research has identified several components of the innate immune system that may play a significant role in chronic rhinosinusitis (CRS), but the role of innate immunity in patients with CRS is poorly understood. The objective of this study was to determine differential expression of innate immunity genes in the mucosa of patients with CRS with nasal polyposis (CRSwNP) and CRS without nasal polyposis (CRSsNP) when compared with controls.Methods: Control patients (n = 9) and patients with CRS (n = 36) who failed medical management were prospectively enrolled. Ethmoid mucosa samples were harvested during surgery and quantitative real-time polymerase chain reaction was used to determine levels of mRNA expression of Toll-like receptor (TLR) 2 and TLR9 and interleukin-22 receptor (IL-22R). The average change in crossover threshold and fold change were calculated and differences between controls, CRSwNP, and CRSsNP were compared. Statistical analysis was performed using the Kruskall-Wallis and adjusted Mann-Whitney U tests.Results: Patients with CRSwNP (n = 16) and CRSsNP (n = 20) showed lower mean expression of TLR2 (p <0.05) compared with controls. Patients with CRSsNP showed significantly higher mean expression of IL-22R (p <0.05) than controls.Conclusion: The sinonasal innate immune system may have a significant role in the development of CRS. We found differential expression of innate immune mediators between patients with and without nasal polyposis. These results provide further evidence of disruption of innate immunity at the mucosal level in CRS and highlight differences between polyp- and non-polyp-forming CRS phenotypes at the molecular level. In addition to our knowledge, this is the first report of altered IL-22R expression in CRSsNP patients. This study was a part of the clinical trial NCT01332136 registered in www. clinicaltrials.gov.",
author = "Detwiller, {Kara Y.} and Timothy Smith and Alt, {Jeremiah A.} and Dennis Trune and Mace, {Jess C.} and Nathan Sautter",
year = "2014",
month = "9",
day = "1",
doi = "10.2500/ajra.2014.28.4082",
language = "English (US)",
volume = "28",
pages = "374--377",
journal = "American Journal of Rhinology and Allergy",
issn = "1945-8924",
publisher = "OceanSide Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Differential expression of innate immunity genes in chronic rhinosinusitis

AU - Detwiller, Kara Y.

AU - Smith, Timothy

AU - Alt, Jeremiah A.

AU - Trune, Dennis

AU - Mace, Jess C.

AU - Sautter, Nathan

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Background: Prior research has identified several components of the innate immune system that may play a significant role in chronic rhinosinusitis (CRS), but the role of innate immunity in patients with CRS is poorly understood. The objective of this study was to determine differential expression of innate immunity genes in the mucosa of patients with CRS with nasal polyposis (CRSwNP) and CRS without nasal polyposis (CRSsNP) when compared with controls.Methods: Control patients (n = 9) and patients with CRS (n = 36) who failed medical management were prospectively enrolled. Ethmoid mucosa samples were harvested during surgery and quantitative real-time polymerase chain reaction was used to determine levels of mRNA expression of Toll-like receptor (TLR) 2 and TLR9 and interleukin-22 receptor (IL-22R). The average change in crossover threshold and fold change were calculated and differences between controls, CRSwNP, and CRSsNP were compared. Statistical analysis was performed using the Kruskall-Wallis and adjusted Mann-Whitney U tests.Results: Patients with CRSwNP (n = 16) and CRSsNP (n = 20) showed lower mean expression of TLR2 (p <0.05) compared with controls. Patients with CRSsNP showed significantly higher mean expression of IL-22R (p <0.05) than controls.Conclusion: The sinonasal innate immune system may have a significant role in the development of CRS. We found differential expression of innate immune mediators between patients with and without nasal polyposis. These results provide further evidence of disruption of innate immunity at the mucosal level in CRS and highlight differences between polyp- and non-polyp-forming CRS phenotypes at the molecular level. In addition to our knowledge, this is the first report of altered IL-22R expression in CRSsNP patients. This study was a part of the clinical trial NCT01332136 registered in www. clinicaltrials.gov.

AB - Background: Prior research has identified several components of the innate immune system that may play a significant role in chronic rhinosinusitis (CRS), but the role of innate immunity in patients with CRS is poorly understood. The objective of this study was to determine differential expression of innate immunity genes in the mucosa of patients with CRS with nasal polyposis (CRSwNP) and CRS without nasal polyposis (CRSsNP) when compared with controls.Methods: Control patients (n = 9) and patients with CRS (n = 36) who failed medical management were prospectively enrolled. Ethmoid mucosa samples were harvested during surgery and quantitative real-time polymerase chain reaction was used to determine levels of mRNA expression of Toll-like receptor (TLR) 2 and TLR9 and interleukin-22 receptor (IL-22R). The average change in crossover threshold and fold change were calculated and differences between controls, CRSwNP, and CRSsNP were compared. Statistical analysis was performed using the Kruskall-Wallis and adjusted Mann-Whitney U tests.Results: Patients with CRSwNP (n = 16) and CRSsNP (n = 20) showed lower mean expression of TLR2 (p <0.05) compared with controls. Patients with CRSsNP showed significantly higher mean expression of IL-22R (p <0.05) than controls.Conclusion: The sinonasal innate immune system may have a significant role in the development of CRS. We found differential expression of innate immune mediators between patients with and without nasal polyposis. These results provide further evidence of disruption of innate immunity at the mucosal level in CRS and highlight differences between polyp- and non-polyp-forming CRS phenotypes at the molecular level. In addition to our knowledge, this is the first report of altered IL-22R expression in CRSsNP patients. This study was a part of the clinical trial NCT01332136 registered in www. clinicaltrials.gov.

UR - http://www.scopus.com/inward/record.url?scp=84907443650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907443650&partnerID=8YFLogxK

U2 - 10.2500/ajra.2014.28.4082

DO - 10.2500/ajra.2014.28.4082

M3 - Article

VL - 28

SP - 374

EP - 377

JO - American Journal of Rhinology and Allergy

JF - American Journal of Rhinology and Allergy

SN - 1945-8924

IS - 5

ER -